Cite
HARVARD Citation
Bazzi, Z. et al. (2016). Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates breast cancer cell metastatic behaviors through inhibition of plasminogen activation and extracellular proteolysis. BMC cancer. 16 (1), pp. 1-12. [Online].